AFP and hepatocellular carcinoma: In our study, in agreement with previous findings [10,26,27,28], the combined use of AFP + PIVKA-II led to a good diagnostic accuracy for the detection of HCC (AUC = 0.822); even including in the analysis only patients with early HCC, the combined performance of AFP + PIVKA-II remained satisfactory (AUC = 0.802).